Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 912,165 |
|
|||||
| News | - | ||||||
| Day High | 6.16 | Low High |
|||||
| Day Low | 5.945 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Cogent Biosciences Inc | COGT | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.01 | 0.17% | 6.02 | 15:03:26 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 6.02 | 5.945 | 6.16 | 6.02 | 6.01 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6,845 | 912,165 | US$ 6.02 | US$ 5,494,290 | - | 3.67 - 13.50 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 16:04:51 | 1 | US$ 5.90 | USD |
Cogent Biosciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 244.2M | 103.91M | - | 0 | -192.41M | -1.85 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Cogent Biosciences News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical COGT Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 6.58 | 7.40 | 5.88 | 6.64 | 1,321,400 | -0.56 | -8.51% |
| 1 Month | 6.73 | 7.40 | 5.88 | 6.67 | 1,304,691 | -0.71 | -10.55% |
| 3 Months | 4.38 | 10.26 | 4.30 | 7.26 | 2,212,928 | 1.64 | 37.44% |
| 6 Months | 8.79 | 10.26 | 3.67 | 6.48 | 2,002,982 | -2.77 | -31.51% |
| 1 Year | 10.73 | 13.50 | 3.67 | 7.82 | 1,359,969 | -4.71 | -43.90% |
| 3 Years | 8.67 | 18.07 | 3.67 | 9.08 | 983,717 | -2.65 | -30.57% |
| 5 Years | 2.20 | 18.07 | 2.20 | 9.03 | 904,095 | 3.82 | 173.64% |
Cogent Biosciences Description
| Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. |
